PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34462437-4	2021	Here, we study antisense oligonucleotides (ASOs) as a therapeutic modality, interfering with the PLN/SERCA2a interaction by targeting Pln mRNA for downregulation in the heart of murine HF models.	Oligonucleotides, Antisense	43-47	phospholamban	Mus musculus	97-100	
27811197-7	2017	Subsequently, male C57BL/6 mice were subjected to sham or transverse aortic constriction surgery; after 3 weeks, these were treated with PLN-targeting LNA-ASO (0.3 mg/kg) or scrambled LNA-ASO.	Oligonucleotides, Antisense	155-158	phospholamban	Mus musculus	137-140	
34462437-4	2021	Here, we study antisense oligonucleotides (ASOs) as a therapeutic modality, interfering with the PLN/SERCA2a interaction by targeting Pln mRNA for downregulation in the heart of murine HF models.	Oligonucleotides, Antisense	43-47	phospholamban	Mus musculus	134-137